Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2014; 20(16): 4491-4502
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4491
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4491
Ref. | Year | Institute of adscription of corresponding author-city | Main finding | Quantity and type of groups studied |
[67] | 2013 | UG Guadalajara, Jalisco | EGFR-R521K and ERBB2-1655V polymorphisms are not suitable as markers for identifying individuals at risk of developing gastric cancer | 155 gastric cancer 121 controls 103 general population |
[62] | 2013 | INCMSZ Mexico City | HER2 amplification is restricted to intestinal gastric cancer. HER2 amplification is suitable as a marker for screening gastric cancer histotype | 269 gastric cancer |
[59] | 2010 | UV Xalapa, Veracruz | MMP9 expression is enhanced in gastric cancer compared to normal mucosa, and has potential as a molecular marker | 6 gastric cancer 11 superficial gastritis |
[68] | 2010 | UNAM Mexico City | Claudin 6, 7, and 9 expression is related to gastric carcinogenesis, and detection of these is a useful prognostic marker in intestinal and diffuse gastric cancer | 70 gastric cancer |
[60] | 2010 | IMSS Mexico City | Polymorphisms in TNF and HSP70 have a severity dose-response as risk markers from preneoplastic lesions to gastric cancer, probably because of their association with an intense and sustained inflammatory response | 228 non atrophic gastritis 98 intestinal metaplasia 63 gastric cancer 58 duodenal ulcer 132 controls |
[63] | 2009 | INSP Cuernavaca, Morelos | In subjects with high consumption of folate, choline and vitamin B6, and 5,10-methylenetetrahydrofolate reductase (MTHFR) 677 TT genotype, there is a reduction in diffuse gastric risk compared to MTHFR 677 CC + CT carriers. In subjects with low consumption of methionine and MTHFR 677 TT genotype, there is a reduced risk of diffuse gastric cancer compared to MTHFR 677 CC + CT carriers. Carriers of the MTHFR 677 TT genotype with a low consumption of folate have a significantly increased risk of development of intestinal gastric cancer | 248 gastric cancer 478 controls |
[69] | 2007 | UANL Monterrey, Nuevo Leon | There is no association between the MTHFR C677T polymorphism and development of gastric cancer | 51 gastric cancer 83 controls |
[57] | 2007 | INCMSZ Mexico City | The -160 C/A polymorphism of E-cadherin has a direct effect on the risk of diffuse gastric cancer at a young age | 39 gastric cancer younger than 45 years of age 78 controls |
[61] | 2007 | UANL Monterrey, Nuevo Leon | The IL-8-251*A allele could be related to the development of gastric cancer | 78 gastric cancer 259 controls |
[70] | 2006 | INSP Cuernavaca, Morelos | High prevalence of MTHFR 677T allele may be a contributor to the high rate of morbidity and mortality in gastric cancer | 201 gastric cancer 427 controls |
[71] | 2006 | LSU1 New Orleans, United States | Identification of the IL-1B-31 promoter polymorphism is a useful marker for the risk of intestinal type gastric cancer in subjects with CagA+H. pylori infection | 183 gastric cancer 377 controls |
[58] | 2005 | NYU2 New York, United States | Carrying the Arg/Arg genotype in the codon 72 exon 4 of p53 is associated with risk of development of gastric cancer | 65 gastric cancer 182 controls |
[72] | 2005 | UANL Monterrey, Nuevo Leon | Carrying the proinflammatory IL-1B-31*C allele is associated with increased risk of gastric cancer | 63 gastric cancer 215 controls |
[73] | 2004 | INCan Mexico City | There is an association of major histocompatibility complex HLA-DQA1*0601 and HLA-DQB1*0501 alleles in gastric cancer compared to chronic gastritis and the healthy condition. These HLA-DQ alleles may be conferring susceptibility for the development of gastric cancer | 20 gastric cancer 40 H. pylori-associated chronic gastritis 90 controls |
[74] | 2003 | UANL Monterrey, Nuevo Leon | Carrying the pro-inflammatory IL-1B-31*C allele is associated with an increased risk of gastric cancer and high-grade dysplasia | 33 gastric cancer 8 high-grade dysplasia 25 controls |
- Citation: Sampieri CL, Mora M. Gastric cancer research in Mexico: A public health priority. World J Gastroenterol 2014; 20(16): 4491-4502
- URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4491.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4491